SCHEMBL28417752

SCHEMBL28417752

N[C@H](C(=O)O)C(CC(=O)O)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
SLC1A3 P43003 6/20 0.44
SLC1A2 P43004 6/20 0.44
SLC1A1 P43005 6/20 0.44
EPHX1 P07099 1/20 0.39
GRIK1 P39086 2/20 0.39
DPP4 P27487 1/20 0.39
SHBG P04278 1/20 0.38
GRIK2 Q13002 1/20 0.37
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
TP53 P04637 1/20 0.35
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22356812 0.87 ALDH1A1 (0.43) ALDH1A1SLC1A3SLC1A2SLC1A1EPHX1
SCHEMBL18680576 0.85 SLC1A3 (0.41) ALDH1A1SLC1A3SLC1A2SLC1A1EPHX1
SCHEMBL288891 0.81 SHBG (0.57) ALDH1A1SLC1A3SLC1A2SLC1A1EPHX1
SCHEMBL28758251 0.81 SHBG (0.57) ALDH1A1SLC1A3SLC1A2SLC1A1EPHX1
SCHEMBL27644093 0.79 SHBG (0.54) ALDH1A1SLC1A3SLC1A2SLC1A1EPHX1
SCHEMBL27665614 0.79 SLC7A5 (0.42) ALDH1A1SLC1A3SLC1A2SLC1A1EPHX1
SCHEMBL5323173 0.77 SLC1A2 (0.38) ALDH1A1SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL5323179 0.77 SLC1A2 (0.38) ALDH1A1SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL5520204 0.77 ALDH1A1 (0.52) ALDH1A1EPHX1SHBGCYP2C19
SCHEMBL5416686 0.76 ALDH1A1 (0.60) ALDH1A1EPHX1GRIK1DPP4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111372942-A β -catenin function modulating agents and methods thereof 弗格制药有限公司 2020-07-03 CN claimed
CN-111372942-A β -catenin function modulating agents and methods thereof 弗格制药有限公司 2020-07-03 CN disclosed